Pharma, Biotech & Medtech in Switzerland 2026: Jobs and Salaries
Switzerland hosts two of the world's five largest pharmaceutical companies — Roche and Novartis, both headquartered in Basel — along with a world-class biotech cluster, major medtech manufacturers and the regulatory authority Swissmedic. The sector employs over 50,000 people and consistently pays above Swiss national averages. For expats with life sciences backgrounds, it offers some of the most accessible and rewarding career paths in the country.
The Swiss life sciences sector is geographically concentrated but economically enormous. Basel is its historic heart: Roche's global headquarters and Novartis's campus together form one of the densest pharmaceutical employment clusters in the world. The wider Basel region also hosts Johnson & Johnson, Solvias, Bachem and dozens of contract research and manufacturing organisations. Zurich and the Lake Geneva arc (Vaud and Geneva) host biotech startups, EPFL spin-offs, and the medtech operations of companies such as Medtronic, Becton Dickinson, and Terumo.
The sector is highly international by nature: clinical trials require global expertise, regulatory submissions demand knowledge of EMA, FDA and Swissmedic frameworks simultaneously, and manufacturing sites operate to GMP standards that transcend national borders. English is the working language at most multinational sites, which makes Switzerland's pharma sector one of the most accessible for non-German-speaking expats.
- Major employers: Roche (Basel, ~10,000 employees in Switzerland), Novartis (Basel, ~11,000), Johnson & Johnson (Zug/Zurich), Lonza (Basel/Visp), Medtronic (Tolochenaz), Beckman Coulter, Terumo, and hundreds of biotech start-ups.
- Salaries: specialist (3–7 years, e.g. QA, regulatory, clinical) CHF 90,000–130,000; regulatory affairs director CHF 140,000–200,000; medical director / VP CHF 180,000–250,000+.
- Most in-demand roles: regulatory affairs (Swissmedic/EMA/FDA), quality assurance and GMP validation, clinical operations, medical science liaisons, bioinformatics, and process engineers for biologics manufacturing.
- Key certifications valued: GMP qualifications, ICH E6(R2) GCP, ISO 13485 for medtech, PMP for clinical project managers.
- Languages: English is the primary working language at most multinationals; German is useful in Basel; French in the Vaud/Geneva corridor.
The Basel biotech cluster and major employers
Roche Holding is the world's largest oncology company and its Basel campus is a city within a city, employing thousands of scientists, engineers, regulatory professionals, and commercial staff. The company recruits globally and offers structured entry paths for post-doctoral researchers, junior regulatory affairs officers and manufacturing engineers. Novartis's campus in neighbouring Novartis Campus Basel is one of the most architecturally striking corporate sites in the world and similarly hires from a global talent pool, with a particular appetite for digital health, data science applied to drug discovery, and early-clinical professionals.
Lonza, headquartered in Basel with major manufacturing operations in Visp (Valais), is the world's leading contract development and manufacturing organisation (CDMO) for biologics. It employs process engineers, quality systems specialists and regulatory professionals at scale. The company's rapid growth driven by mRNA manufacturing contracts (including COVID-19 vaccines) created a hiring surge that continues to generate openings in 2026.
Expat pathways into Swiss pharma
For EU nationals, the path into Swiss pharma is straightforward: a Permit B linked to an employment contract is processed quickly for qualified candidates, and employers in Basel are experienced at managing cross-border hires. For non-EU nationals (US, UK, India, China — common profiles in pharma), the employer must demonstrate that no suitable Swiss or EU candidate was available, which is generally satisfied for specialised technical or scientific roles.
The most effective application strategy for expats is to target roles at Roche, Novartis, Lonza and J&J through their direct careers portals, where applications go directly to internal talent acquisition teams. Specialist pharma recruitment agencies — many based in Basel — also play an important role for mid-career lateral moves. A CV that highlights GMP experience, regulatory submission history (dossiers submitted, markets covered) and specific software proficiency (Veeva, LIMS, SAP QM) will consistently outperform generic life sciences CVs in Swiss ATS systems.
Frequently asked questions
What language do I need to work at Roche or Novartis in Basel?
English is the primary working language at both Roche and Novartis's Basel campuses — scientific, regulatory and management functions operate in English, and non-German-speaking professionals can be hired, progress and build long careers there. German is valued for daily life in Basel and for interactions with local authorities or service providers, and Swiss German is the informal language of the city. For laboratory-facing or production roles at Lonza Visp or at satellite sites outside Basel, German proficiency becomes more important.
What do regulatory affairs specialists earn in the Swiss pharma industry?
A regulatory affairs specialist with three to seven years of experience earns CHF 90,000–130,000 at a major Swiss pharma company. Senior regulatory affairs managers overseeing global submissions (Swissmedic, EMA, FDA) earn CHF 120,000–160,000, and regulatory affairs directors can reach CHF 140,000–200,000 at Roche or Novartis. These are among the highest regulatory affairs salaries in the world, reflecting both Switzerland's cost of living and the strategic importance of the function to companies generating billions in revenue from each approval.
How does applying to a pharma giant differ from applying to a Swiss biotech startup?
At Roche, Novartis or Lonza, applications go through structured ATS systems (Workday, SuccessFactors) with defined competency frameworks, multiple interview rounds and formal offer processes that can take eight to sixteen weeks. Swiss biotech startups — particularly EPFL or ETH spin-offs around Lausanne and Zurich — tend to hire faster and weight personal fit and specific technical skills more heavily; founders often interview candidates directly. Startups typically offer below-market base salaries (CHF 80,000–120,000 for senior roles) partially offset by equity, whereas the pharma giants offer no meaningful equity but very competitive base salaries and defined benefits.